The cGAS-STING Pathway in Pulmonary Diseases: Mechanisms and Therapeutic Potential

Area of Science:

• Immunology
• Pulmonology
• Molecular Biology

Background:

• The cGAS-STING pathway is a key innate immune sensor for cytosolic DNA in the lung.
• It plays a critical role in recognizing microbial infections and tissue damage, initiating immune responses.
• Dysregulation of this pathway is implicated in exacerbating lung diseases like COPD, fibrosis, and cancer.

Purpose of the Study:

• To review the fundamental mechanisms of the cGAS-STING pathway.
• To explore its multifaceted roles in various pulmonary diseases.
• To summarize current therapeutic strategies targeting the cGAS-STING pathway for lung conditions.

Main Methods:

• Comprehensive literature review of studies on the cGAS-STING pathway in pulmonary diseases.
• Analysis of research on cGAS-STING agonists and inhibitors.
• Synthesis of information on the pathway's role in inflammation and fibroblast proliferation.

Main Results:

• The cGAS-STING pathway is essential for anti-viral and anti-tumor immunity in the lung.
• Aberrant cGAS-STING signaling contributes to chronic inflammation and disease progression in COPD, pulmonary fibrosis, and lung cancer.
• Numerous cGAS-STING modulators (agonists and inhibitors) are under investigation for therapeutic applications.

Conclusions:

• The cGAS-STING pathway presents a significant therapeutic target for a range of pulmonary diseases.
• Understanding its dual role in immunoregulation is crucial for developing effective treatments.
• Targeting cGAS-STING signaling offers promising new avenues for managing lung pathologies.